Transactions
3
Insider / QUEST DIAGNOSTICS INC
RING TIMOTHY M
Director at QUEST DIAGNOSTICS INC
- Company
- QUEST DIAGNOSTICS INC
- First filing on record
- October 3, 2025
- Latest trade on record
- May 20, 2026
- SEC filings
- EDGAR ↗
RING TIMOTHY M, Director at QUEST DIAGNOSTICS INC, has disclosed 3 transactions in DGX, BDX since October 3, 2025: 0 purchases (0 open-market buys) and 0 sales, worth about $0 at the reported prices. The latest was filed May 21, 2026, 1 day after the trade.
Open-market buys
0
Sales
0
Avg. disclosure lag
1.7d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months RING TIMOTHY M reported 2 transactions that were neither a purchase nor a sale, such as stock awards, option exercises or shares withheld for tax.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 3 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 3 | 2,473 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 2 | 0 | 0 |
| 2025 | 1 | 0 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| DGX | Other A | May 20, 2026 | May 21, 2026 | 1d | 1,142 | — | — | Form 4 ↗ | ||
| BDX | Other A | January 27, 2026 | January 29, 2026 | 2d | 1,098 | — | — | Form 4 ↗ | ||
| DGX | Other A | October 1, 2025 | October 3, 2025 | 2d | 233 | — | — | derivative | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 21, 2026 | Form 4 | 0001204666-26-000002 | 1 | published | EDGAR ↗ |
| January 29, 2026 | Form 4 | 0001628280-26-004004 | 1 | published | EDGAR ↗ |
| October 3, 2025 | Form 4 | 0001022079-25-000207 | 1 | published | EDGAR ↗ |
Other insiders at QUEST DIAGNOSTICS INC
- DELANEY MARK E SVP & Chief Commercial Officer 17 rows
- Doherty Catherine T. EVP, Regional Businesses 17 rows
- Plewman Patrick SVP for Diagnostic Services 17 rows
- Davis J. E. CEO and President 16 rows
- KUPPUSAMY KARTHIK SVP, Clinical Solutions 16 rows
- PREVOZNIK MICHAEL E SVP & General Counsel 16 rows
- Feld Michael EVP, Chief Revenue Officer 15 rows
- SAMAD SAM Executive Vice President & CFO 13 rows
- Garrison Michael David EVP & Pres Med.Essntl&BioPharm 11 rows
- Huffines Robert Luther Director 11 rows
Everyone on file, with contracts and lobbying under the company's name: QUEST DIAGNOSTICS INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 3 | 3 | October 3, 2025 | May 21, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.